Hypercholesterolemia – Pipeline Review, H1 2012 (Related Reports)

Hypercholesterolemia – Pipeline Review, H1 2012


March 19, 2012
123 Pages - SKU: GMD3811124
License type:
Online Download      US $500.00
Global Site License      US $1,500.00
Bone Marrow Transplantation - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Bone Marrow Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bone Marrow Transplantation - Pipeline Review, H1 2014’, provides an overview of the Bone Marrow Transplantation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Food Allergy - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Food Allergy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Food Allergy - Pipeline Review, H1 2014’, provides an overview of the Food Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Food  |  read more...
$2,000.00
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight
4/1/2014 | published by: FirstWord
Introduction Approval of Gilead’s once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in  |  read more...
$4,995.00
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018
4/4/2014 | published by: MarketsandMarkets
Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018 Over the  |  read more...
$4,650.00
Pertussis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Pertussis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2014’, provides an overview of the Pertussis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative  |  read more...
$2,000.00
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Klebsiella Pneumoniae Infections - Pipeline Review, H1 2014’, provides an overview of the Klebsiella Pneumoniae Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Polio - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Polio - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Polio - Pipeline Review, H1 2014’, provides an overview of the Polio’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polio, complete with comparative  |  read more...
$2,000.00
Typhoid Fever - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Typhoid Fever - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid  |  read more...
$2,000.00
Perennial Allergic Rhinitis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Perennial Allergic Rhinitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H1 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Severe Psoriasis - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Severe Psoriasis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2014’, provides an overview of the Severe Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Severe  |  read more...
$2,000.00